Search the hub
Showing results for tags 'Vaccination'.
Found 452 results
-
Content ArticleIn this opinion piece for The BMJ, Partha Kar, consultant endocrinologist and NHS England National Specialty Advisor for Diabetes, looks at the crisis facing primary care in the UK. He highlights that many primary care professionals are feeling burnt out due to the intense pressure and negative attention GPs are currently experiencing. The cost of relying on primary care for the vaccination programme is that treatment for mental health and long term conditions has been neglected. GPs are at the receiving end of patients' frustrations about delays to their care. Partha highlights the need to: prepare well in advance for potential future waves of Covid-19, including by developing a vaccine delivery workforce that is not reliant on primary care. ensure vaccines are distributed to less developed countries, and move away from seeing vaccination as an issue of nationalism. increase funding for primary care in a focused and sustained way.
-
Content ArticleIn this interview for Woman's Hour, Dr Nisreen Alwan, Associate Professor in Public Health at the University of Southampton, discusses the impact of Long Covid on her own life with presenter Emma Barnett. She also shares insights from research that suggests women, people of working age, people from areas of high social deprivation and frontline health and education workers are more likely to be affected by Long Covid. Dr Alwan talks about the need to manage Long Covid alongside daily activities and highlights new research that demonstrates that vaccines may reduce the incidence of the condition. The interview can be heard at 17:23-25:20 in the recording.
-
Content ArticleIn this interview with the journal International Politics and Society, Brendan Delaney, professor at the Faculty of Medicine at Imperial College London discusses the impact of Long Covid on individuals and society. He describes his own experience of Long Covid, which rendered him unable to work for months, and highlights that we should not be surprised by the prevalence of Long Covid, as all epidemics result in long-term illness for many people. He draws attention to parts of the political system 'not believing in' Long Covid and highlights the damage caused by psychologising the condition. Finally, he points to the need for more research to better understand Long Covid symptoms.
-
Content ArticleIt is particularly important that severely immunosuppressed people receive their booster given the new dominant Omicron variant. However, this is causing some difficulties as the system does not currently distinguish between a third primary dose and a booster. This update from the Royal College of Physicians provides guidance for doctors on identifying severely immunosuppressed patients who are eligible for a booster vaccine, having already had a third primary dose.
-
Content ArticleIn this opinion piece in The Guardian, Gabriel Scally, professor of public health and member of the Independent Sage committee, argues that the government's response to Covid-19 relies on personal responsibility rather than public health measures. He highlights that this will not be adequate to get the pandemic under control. The author states that a public health-focused response should have three pillars: prevention, vaccination and control, but at the moment the government is using just one of these. He draws attention to the issue of resources being wasted on handwashing and sanitisation, when Covid-19 is primarily airborne, and argues that funding should be redirected to investing in ventilation improvements and promoting the use of more effective face coverings. He also highlights the failure of contact tracing in the UK, and calls for renewed efforts to develop a comprehensive public health response in light of the new Omicron strain.
-
Content Article
Long Covid: The hidden iceberg of Covid-19
Dr Shruthi posted an article in Blogs
In the wake of new variants and the relentless spread of Covid-19, understanding the complex nature of Long Covid is crucial. In this article, I aim to present useful information on the risk factors, plausible pathophysiological mechanisms and treatment of Long Covid. The obscure nature of Long Covid is a conundrum both for doctors and patients. To mitigate the burden of Long Covid, early identification of disease signs, appropriate treatment and timely access to rehabilitation care is vital. I believe that strengthening the 4 Rs (Reporting, Recognition, Rehabilitation and Research) through close collaboration between government organisations, pharmaceutical industries, patients and health care providers could reduce the impact of Long Covid. -
Content ArticleA post on Doctors in Unite website argue that COVID-19 guidelines are fundamentally flawed and not fit for purpose, putting health care workers and patients at serious risk. IPC authorities are increasingly isolated in their view that COVID-19 is spread by droplets and not through the air, a position which is directly contradicted now by official government policy. This article takes a more detailed look at the issues, which demonstrates how unscientific, out of touch and indeed hazardous the guidelines are for health workers and patients.
-
Content ArticleThe Chief Medical Officers (CMOs) of the UK and lead Deputy Chief Medical Officers (DCMOs) for vaccines have considered whether, in the light of the very considerable need to speed up vaccination and boosting in response to Omicron variant, the 15-minute wait for some mRNA COVID-19 vaccines should be suspended. Their view, having considered the views of the COVID-19 Vaccine Benefit-Risk Expert Working Group (EWG), NHS planners and others is that with the low rates of anaphylaxis, in the context of the considerable need for people to be boosted or vaccinated, the 15-minute wait after a vaccination with mRNA vaccine will cause more harm than it can avert because it will significantly reduce the number of people who can be vaccinated over a short period of time. The 15-minute wait should therefore be suspended for first, second and homologous or heterologous boost vaccinations with mRNA vaccine given the current situation, with this operationalised in line with the needs in each of the 4 nations.
-
Content Article
Vaccinating a Nation: Lessons from Scotland (CIEHF)
Patient Safety Learning posted an article in Guidance
This is the Chartered Institute of Ergonomics and Human Factors (CIEHF)'s second guide in response to issues concerning vaccination and COVID-19. It documents the key learnings gained from the human factors assessment of the vaccination system implemented by NHS Ayrshire & Arran (NHSAA). Its purpose is to share success, recommend design and safety improvements and offer a universal template for future safe and effective rollouts of time-critical vaccination programmes. The guidance will also be useful for the design and delivery of any public health vaccination programmes post COVID-19. Further reading CIEHF: COVID-19 human factor response -
Content ArticleThis report provides an update on cross-government work to address the disparities highlighted by the Public Health England report 'COVID-19: review of disparities in risks and outcomes', published in June 2020. It sets out how the Government's understanding of and response to the pandemic changed over the lifecycle of this work. The report also includes a summary of progress against recommendations from previous reports, lessons learned from this work and an action plan for addressing some of the longer-term issues identified.
-
Content ArticleIn this BMJ paper, Jin-Ling Tang and Li-Ming Li argue that despite the lure of vaccines and new drugs, established public health measures will remain our best tool to control COVID-19 and future epidemics
-
Content ArticleOn 1 February the UK Health Security Agency warned that coverage of the measles, mumps, and rubella (MMR) vaccine’s first dose had dropped below 90% in 2 year olds. By age 5, uptake of two doses had dropped to 85.5%—well below the World Health Organization’s 95% target needed for elimination of measles. The latest quarterly vaccination figures show very small drops in uptake in England from July to September 2020, and uptake continued to decline over the next year. And it’s not just MMR: small decreases have been seen in coverage of other childhood vaccines including the combined diphtheria, hepatitis B, Hib, polio, tetanus, and whooping cough vaccine, as well as those for rotavirus and meningitis B. But MMR is the one that public health officials worry about most because of historically lower uptake and the risks of outbreaks. With uptake of the MMR vaccine falling in the UK, Emma Wilkinson examines whether anti-vaccination sentiment around Covid-19 has played a part.
-
Content ArticleThis free e-learning course by the World Health Organization (WHO) examines the five general steps of inequality monitoring in the context of immunisation programmes. The 'WHO Immunization Agenda 2030: a global strategy to leave no one behind' envisions “a world where everyone, everywhere, at every age, fully benefits from vaccines for good health and well-being.” The course is approximately two hours long and is primarily aimed at monitoring and evaluation officers for immunisation, and people who have basic knowledge and experience working with immunisation data.
-
Content ArticleThe Covid-19 vaccination programme has been one of the few almost unqualified successes of the UK’s response to the pandemic. System-working, joining up the NHS, local government and the voluntary sector was a hallmark of the vaccine roll-out. Local knowledge and delivery were crucial. Volunteers also played a vital role, not just in acting as stewards at vaccination sites, but also in terms of community outreach, for example with faith communities and others offering sites for vaccination which in turn built trust in the vaccine and in the NHS. The NHS has never used so much data so quickly and so powerfully, supporting the delivery of vaccine doses, recording any adverse reactions and, most importantly, allowing NHS staff to map who had the vaccine. This data in turn supported outreach work to support gaps in service provision and overcome vaccine hesitancy. These factors which helped make the roll out a success should be ‘bottled and re-used’ for other NHS services, from childhood immunisations to screening for cancer, diabetes, high blood pressure and other conditions, improving the service’s ability to reach the harder to reach Based on interviews with a wide range of people involved in the programme, this King's Fund report sets out what the roll-out in England has achieved as well as its trials and tribulations.
-
Content ArticleThis blog by the Institute for Safe Medication Practices identifies ten medication safety concerns in the US from 2021 that still need to be addressed. These concerns are: Mix-ups between the paediatric and adult formulations of the Pfizer-BioNTech COVID-19 vaccines Mix-ups between the COVID-19 vaccines or boosters and the 2021-2022 influenza (flu) vaccines EPINEPHrine administered instead of the COVID-19 vaccine Preparation errors with the Pfizer-BioNTech purple cap or grey cap COVID-19 vaccines Errors and delays with hypertonic sodium chloride Errors with discontinued or paused infusions Infection transmission with shared glucometers, fingerstick devices, and insulin pens Adverse glycaemic event errors Every organisation needs a medication safety officer Increasing error reporting
-
Content ArticleThis study in the BMJ Open examines the links between between adverse childhood events and trust in Covid-19 health information, attitudes towards and compliance with Covid-19 restrictions and vaccine hesitancy. The study found correlations between adverse childhood events and: low trust in NHS Covid-19 information feeling unfairly restricted by government supporting removal of social distancing and ending of mandatory face coverings breaking Covid-19 restrictions vaccine hesitancy. The authors concluded that as adverse childhood events are common across many populations, there is a need to understand how they impact trust in health advice and uptake of medical interventions. This could play a critical role in the continuing response to Covid-19 and approaches to controlling future pandemics. In addition, as individuals with adverse childhood events suffer greater health risks throughout life, better compliance with public health advice is another reason to invest in safe, secure childhoods for all children.
-
EventuntilVaccine uptake in the UK is dropping, and we are failing to meet the WHO’s 95% coverage target. To help address this, we must understand people’s attitudes and experiences of vaccines, so we can grasp their concerns and better support them. Children’s attitudes are important too, because they must feel empowered to make health decisions. RSPH research with Children and Young People (CYP) shows that they trust vaccines and think they are important to their health. However, trust varies by ethnicity, with results showing that 85% of white CYP trust vaccines, in comparison to 71% of Asian and 74% of black CYP. Knowledge varies around which vaccines they think are available to them and they do not necessarily know which vaccines they can have. Whilst 61% of CYP understood how vaccines worked, they reported concerns about side effects (63%), safety (57%), whether they will hurt (55%) and the costs of accessing vaccines (16%). These findings have practical implications for practitioners working with CYP and delivering vaccines. In this webinar, we will explore: The impact of inequalities on access to vaccines and information about vaccinations. What challenges the public health workforce face in delivering vaccines. How the workforce – and others involved in vaccine delivery - can be supported to develop and deliver vaccines programmes Register for the webinar
-
EventThis year's conference is all about IPC Legends focusing on individuals who in their respective fields are experts willing to share their knowledge with us, and exploring new ideas in the field of IPS. Alyson Prince – Built Environment Infection Prevention & Control Nurse Specialist/Engineering, Archus Healthcare Infrastructure Specialist who will be covering Ventilation in the Healthcare Setting – What is the air and why is it important. Dave Cunningham – Leadership & Workforce Workstream Lead, NHS Improvement who will be providing an update on the National Infection Prevention IPC Educational framework. Leo Andrew Almerol – Vascular Clinical Nurse Specialist, Imperial College NHS Trust / Vascular Access Nurse 2022, British Journal of Nursing will be providing an update on The Impact of the COVID-19 Pandemic on the Vascular Access Service in the UK. Dr Emily McWhirter – Nurse Consultant, World Health Organization will be sharing with us Leadership and expertise in influencing IPC practice. Professor Elaine Cloutman-Green – Consultant Clinical Scientist (Infection Control Doctor), Great Ormond Street Hospital for Children NHS Foundation Trust is speaking around Challenges in IPC: Aiming for progress not perfection. Dr Mat Moyo – Quality Improvement Mentor / Founder, Quantum Quality Improvement Coaching / Lecturer, Solent University will be speaking to us about Quality Improvement Project Coaching in IPC: Wise People Ask for Help and Get Further!" Sir Jonathan Van- Tam MBE – Former Deputy Chief Medical Officer for England 2017-2022, recording on Learning from the pandemic and the mission of vaccinating the nation will be played before we conclude the day by hearing from Karen Storey – Nursing Retention and Liaison Lead, who will demonstrate to us Shiny Mind app and the benefits to us all for our wellbeing. Register
-
Content ArticleDifferent communities have different needs when it comes to vaccination. Research can show us how to engage with different groups effectively. The latest Collection from the National Institute for Health and Care Research (NIHR) brings together examples of NIHR research on how to increase vaccine uptake.
-
Content Article
The National Vascular Registry (NVR) has published a report on the impact of the Covid-19 pandemic on vascular surgery in the UK, presenting key findings from NVR data throughout 2020 and 2021. NVR previously reported on data as at 25 September 2020, which showed that Covid-19 infection in patients undergoing vascular surgical procedures significantly increased the risk of respiratory complications and mortality. Here, they update this analysis, using data through to the end of 2021, and explore whether the Covid-19 vaccination programme provided protection to patients against this life-threatening complication. One finding is that, between March 2020 and Dec 2021, confirmed postoperative Covid-19 diagnoses were most common among non-elective procedures, ranging from 18.4% (non-elective AAA repair) to 27.5% (major lower limb amputation). For elective procedures, the reported rates of confirmed postoperative Covid-19 diagnoses were lower, ranging from 1.6% (elective AAA repair) to 4.1% (lower-limb bypass). Other key findings include: There was only a modest rise during the first Covid-19 wave (Mar-Jun 2020) with a larger rise during the second wave (Nov 2020-Feb 2021) There was a different pattern for respiratory complications after surgery, with higher rates observed in both wave 1 and wave 2 The period from March to December 2021 was associated with rates of respiratory complications and in-hospital postoperative mortality returning to levels observed pre-pandemic in 2019 Overall, the report concludes that the vaccination programme had a modest benefit to patients in reducing the risk of respiratory complications, and therefore carries a public health message relevant for both national and international audiences. -
Content ArticlePharmacovigilance is the observation and monitoring of possible harms from exposure to a variety of pharmaceuticals, biologics and devices. In this blog, Professor of Evidence-based Medicine Carl Heneghan and Clinical Epidemiologist Tom Jefferson talk about a recent attempt to obtain data on the incidence of deaths following Covid-19 vaccination from the Medicines & Healthcare Products Regulatory Agency (MHRA) through a Freedom of Information request. They describe how the MHRA initially said they were unable to provide the information as it would cost too much to extract, and after sending a follow up request to the MHRA's Chief Safety Officer, they have not heard anything further after an initial promise to investigate. They argue that the MHRA is failing the public by failing to investigate the side effects of Covid vaccines using information from Yellow Card reports. This blog is paywalled once you have read a certain number of articles each month.
-
Content ArticleIn February 2023, the government commissioned an independent review to offer recommendations on how to resolve key challenges in conducting commercial clinical trials in the UK and transform the UK commercial clinical trial environment. The review sets out 27 recommendations, including both priority actions to progress in 2023 and longer-term ambitions for UK commercial clinical trials. The review was conducted by Lord James O’Shaughnessy, Senior Partner at consultancy firm Newmarket Strategy, Board Member of Health Data Research UK (HDR UK) and former Health Minister, who was appointed as review Chair. During the review, Lord O’Shaughnessy consulted closely with industry and a wide range of stakeholders across the UK clinical trials sector. The government response welcomes all recommendations from the review, in principle, and makes 5 headline commitments backed by £121 million. An implementation update, setting out progress made against these commitments and a comprehensive response to the remaining recommendations, will be published in the autumn.
-
Content ArticleIn this letter to The Lancet, Thomas Cueni, Director General of the International Federation of Pharmaceutical Manufacturers and Associations argues that the need to focus on equitable rollout of vaccines in the event of a future pandemic is a key global health priority. He proposes that Governments, pharma companies and other stakeholders should focus on the challenges that led to the inequitable rollout of vaccines, which he identifies as vaccine nationalism and need for more diverse manufacturing. He highlights an industry proposal for equitable response to future pandemics supported by vaccine manufacturers and biotechnologies. the proposal involves manufacturers setting aside a percentage of pandemic tools for allocation to susceptible populations in low-income countries.
-
Content ArticleThe Covid-19 pandemic has shown the power and potential of vaccination in real time. But it has also disrupted health services and caused supply chain challenges, resulting in stagnation and backsliding of routine vaccinations. For example, global coverage of the third dose of the diphtheria–tetanus–pertussis vaccine fell from 86% in 2019 to 81% in 2021—the lowest level since 2008. 25 million children missed out on life-saving measles, diphtheria, and tetanus vaccines in 2021. This editorial in The Lancet calls for a catch-up to return to pre-pandemic vaccination levels and looks at how this can be achieved.
-
News Article
England to offer Covid jab to five to 11-year-olds
Patient Safety Learning posted a news article in News
Children aged between five and 11 in England will be offered a low-dose Covid vaccine, the government says. Official scientific advice concludes the move would help protect the "very small" number of children who become seriously ill with Covid. Health Secretary Sajid Javid says the rollout will be "non-urgent", with an emphasis on parental choice. Northern Ireland also said on Wednesday it will be following Wales and Scotland in offering young children the vaccine. Children are at a much lower risk of becoming severely ill from a Covid infection, so the health benefits of vaccinating them are smaller than in other age-groups. Also, many will have some protection from already having caught the virus. So the scientists on the Joint Committee on Vaccination and Immunisation (JCVI), which advises governments across the UK, have been weighing up the evidence for immunising five to 11-year-olds. It concluded vaccination should go ahead to prevent a "very small number of children from serious illness and hospitalisation" in a future wave of Covid. Prof Wei Shen Lim, from the JCVI, said: "We're offering this to five to 11-year-olds now in order to future-proof their defences against a future wave of infection." He suggested parents consider getting their children vaccinated during school holidays to minimise disruption to their education from any flu-like side effects of the jab. Read full story Source: BBC News, 16 February 2022
